CLLS
Income statement / Annual
Last year (2023), Cellectis S.A.'s total revenue was $755,000.00,
a decrease of 96.06% from the previous year.
In 2023, Cellectis S.A.'s net income was -$101.06 M.
See Cellectis S.A.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$755,000.00 |
$19.17 M |
$73.95 M |
$73.95 M |
$15.19 M |
$12.73 M |
$25.19 M |
$42.58 M |
$55.04 M |
$26.30 M |
| Cost of Revenue |
$737,000.00
|
$1.77 M
|
$36.28 M
|
$36.28 M
|
$11.39 M
|
$2.74 M
|
$2.62 M
|
$1.69 M
|
$2.71 M
|
$3.69 M
|
| Gross Profit |
$18,000.00
|
$17.40 M
|
$37.67 M
|
$37.67 M
|
$3.80 M
|
$9.99 M
|
$22.57 M
|
$40.90 M
|
$52.34 M
|
$22.61 M
|
| Gross Profit Ratio |
0.02
|
0.91
|
0.51
|
0.51
|
0.25
|
0.78
|
0.9
|
0.96
|
0.95
|
0.86
|
| Research and Development Expenses |
$87.65 M
|
$97.50 M
|
$86.95 M
|
$86.95 M
|
$92.04 M
|
$76.57 M
|
$79.23 M
|
$74.56 M
|
$57.30 M
|
$17.52 M
|
| General & Administrative Expenses |
$16.81 M
|
$17.49 M
|
$37.87 M
|
$44.20 M
|
$43.02 M
|
$47.25 M
|
$44.75 M
|
$41.26 M
|
$29.78 M
|
$15.95 M
|
| Selling & Marketing Expenses |
$0.00
|
$3.11 M
|
$6.33 M
|
$1.66 M
|
$11.43 M
|
$16.69 M
|
$9.14 M
|
$8.41 M
|
$6.67 M
|
$6.57 M
|
| Selling, General & Administrative Expenses |
$16.81 M
|
$17.49 M
|
$44.20 M
|
$44.20 M
|
$43.02 M
|
$47.25 M
|
$44.75 M
|
$41.26 M
|
$29.78 M
|
$15.95 M
|
| Other Expenses |
-$7.14 M
|
-$7.93 M
|
-$8.04 M
|
-$8.04 M
|
-$7.71 M
|
-$25.42 M
|
-$17.90 M
|
-$19.38 M
|
-$10.88 M
|
-$11.05 M
|
| Operating Expenses |
$97.32 M
|
$107.07 M
|
$123.11 M
|
$123.11 M
|
$127.35 M
|
$115.08 M
|
$115.22 M
|
$104.86 M
|
$82.87 M
|
$28.98 M
|
| Cost And Expenses |
$98.06 M
|
$108.84 M
|
$159.39 M
|
$159.39 M
|
$138.74 M
|
$117.82 M
|
$117.84 M
|
$106.54 M
|
$85.57 M
|
$32.68 M
|
| Interest Income |
$3.61 M
|
$1.12 M
|
$736,000.00
|
$1.95 M
|
$8.34 M
|
$16.76 M
|
$1.97 M
|
$44,171.00
|
$8.25 M
|
$384,259.00
|
| Interest Expense |
$6.43 M
|
$3.79 M
|
$5.34 M
|
$12.05 M
|
$2.61 M
|
$46,000.00
|
$4,000.00
|
$6,310.21
|
$22,959.00
|
$195,778.00
|
| Depreciation & Amortization |
$18.52 M
|
$18.44 M
|
$14.16 M
|
$9.82 M
|
$6.88 M
|
$2.38 M
|
$3.37 M
|
$2.21 M
|
$1.91 M
|
$1.67 M
|
| EBITDA |
-$92.64 M |
-$76.38 M |
-$86.46 M |
-$34.68 M |
-$105.09 M |
-$93.79 M |
-$108.08 M |
-$65.32 M |
-$26.21 M |
$370,080.00 |
| EBITDA Ratio |
-122.7
|
-4.68
|
-1.16
|
-1.16
|
-8.13
|
-8.25
|
-3.68
|
-1.5
|
-0.52
|
-0.17
|
| Operating Income Ratio |
-141.23
|
-4.68
|
-1.16
|
-1.16
|
-8.13
|
-8.25
|
-3.68
|
-1.5
|
-0.55
|
-0.24
|
| Total Other Income/Expenses Net |
-$16.42 M
|
-$8.94 M
|
$6.73 M
|
-$12.05 M
|
$8.34 M
|
$16.76 M
|
-$11.03 M
|
$47,000.00
|
$8.38 M
|
$8.63 M
|
| Income Before Tax |
-$123.05 M
|
-$98.60 M
|
-$97.48 M
|
-$97.48 M
|
-$115.21 M
|
-$88.33 M
|
-$103.68 M
|
-$63.92 M
|
-$22.27 M
|
$2.25 M
|
| Income Before Tax Ratio |
-162.97
|
-5.14
|
-1.32
|
-1.32
|
-7.58
|
-6.94
|
-4.12
|
-1.5
|
-0.4
|
0.09
|
| Income Tax Expense |
-$6.21 M
|
$87,000.00
|
-$11.20 M
|
-$24.91 M
|
-$24.53 M
|
$16.81 M
|
-$13.20 M
|
-$1.54 M
|
-$926,027.16
|
$2.42 M
|
| Net Income |
-$101.06 M
|
-$98.69 M
|
-$86.28 M
|
-$72.57 M
|
-$90.69 M
|
-$78.69 M
|
-$99.37 M
|
-$63.92 M
|
-$22.46 M
|
$24,320.00
|
| Net Income Ratio |
-133.85
|
-5.15
|
-1.17
|
-0.98
|
-5.97
|
-6.18
|
-3.95
|
-1.5
|
-0.41
|
0
|
| EPS |
-1.77 |
-2.17 |
-1.93 |
-1.71 |
-2.14 |
-1.93 |
-2.78 |
-1.81 |
-0.66 |
0.0009 |
| EPS Diluted |
-1.77 |
-2.17 |
-1.93 |
-1.71 |
-2.14 |
-1.93 |
-2.78 |
-1.78 |
-0.65 |
0.0009 |
| Weighted Average Shares Out |
$57.01 M
|
$45.55 M
|
$44.82 M
|
$42.50 M
|
$42.44 M
|
$40.77 M
|
$35.69 M
|
$35.29 M
|
$34.15 M
|
$26.07 M
|
| Weighted Average Shares Out Diluted |
$57.01 M
|
$45.55 M
|
$44.82 M
|
$42.50 M
|
$42.44 M
|
$40.77 M
|
$35.69 M
|
$35.81 M
|
$34.52 M
|
$26.19 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
